MicroRNA-15a, microRNA-15b and microRNA-16 inhibit the human dopamine D1 receptor expression in four cell lines by targeting 3′UTR –12 bp to + 154 bp

References

• Tiihonen J, Lonnqvist J, Wahlbeck K, et al. 11-Year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009; 374(9690):620–627.
   PubMed Web of Science ®Google Scholar
• Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III – the final common pathway. Schizophr Bull. 2009;35(3):549–562.
   PubMed Web of Science ®Google Scholar
• Abi-Dargham A, Moore H. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist. 2003;9(5):404–416.
   PubMed Web of Science ®Google Scholar
• Masana M, Santana N, Artigas F, et al. Dopamine neurotransmission and atypical antipsychotics in prefrontal cortex: a critical review. Curr Top Med Chem. 2012;12(21):2357–2374.
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev.. 2011;63(1):182–217.
   PubMed Web of Science ®Google Scholar
• Missale C, Nash SR, Robinson SW, et al. Dopamine receptors: from structure to function. Physiol Rev. 1998;78(1):189–225.
   PubMed Web of Science ®Google Scholar
• Undieh AS. Pharmacology of signaling induced by dopamine D(1)-like receptor activation. Pharmacol Therap. 2010; 128(1):37–60.
   PubMed Web of Science ®Google Scholar
• Kern A, Mavrikaki M, Ullrich C, et al. Hippocampal dopamine/DRD1 signaling dependent on the ghrelin receptor. Cell. 2015;163(5):1176–1190.
   PubMed Web of Science ®Google Scholar
• Baetu I, Burns NR, Urry K, et al. Commonly-occurring polymorphisms in the COMT, DRD1 and DRD2 genes influence different aspects of motor sequence learning in humans. Neurobiol Learn Mem. 2015;125:176–188.
   PubMed Web of Science ®Google Scholar
• Homberg JR, Olivier JD, VandenBroeke M, et al. The role of the dopamine D1 receptor in social cognition: studies using a novel genetic rat model. Dis Model Mech. 2016;9(10):1147–1158.
   PubMed Web of Science ®Google Scholar
• Zhu F, Yan CX, Wang Q, et al. An association study between dopamine D1 receptor gene polymorphisms and the risk of schizophrenia. Brain Res. 2011;1420:106–113.
   PubMed Web of Science ®Google Scholar
• Sedvall G, Pauli S, Karlsson P, et al. PET imaging of neuroreceptors in schizophrenia. Eur Neuropsychopharmacol. 1995;5:25–30.
   PubMed Web of Science ®Google Scholar
• Ota VK, Spindola LN, Gadelha A, et al. DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs. Schizophr Res. 2012;142(1–3):206–208.
   PubMed Web of Science ®Google Scholar
• Azogu I, de la Tremblaye PB, Dunbar M, et al. Acute sleep deprivation enhances avoidance learning and spatial memory and induces delayed alterations in neurochemical expression of GR, TH, DRD1, pCREB and Ki67 in rats. Behav Brain Res. 2015;279:177–190.
   PubMed Web of Science ®Google Scholar
• Azkona G, Sagarduy A, Aristieta A, et al. Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in L-DOPA-treated rats. Neuropharmacology. 2014;79:726–737.
   PubMed Web of Science ®Google Scholar
• Xiao J, Li Y, Prandovszky E, et al. MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway. Neuroscience. 2014;268:128–138.
   PubMed Web of Science ®Google Scholar
• Krichevsky AM, King KS, Donahue CP, et al. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA. 2003;9(10):1274–1281.
   PubMed Web of Science ®Google Scholar
• Huang W, Li MD. Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. Biol Psychiat. 2009;65(8):702–705.
   PubMed Web of Science ®Google Scholar
• Huang W, Ma JZ, Payne TJ, et al. Significant association of DRD1 with nicotine dependence. Hum Genet. 2008;123(2):133–140.
   PubMed Web of Science ®Google Scholar
• Tobon KE, Chang D, Kuzhikandathil EV. MicroRNA 142-3p mediates post-transcriptional regulation of D1 dopamine receptor expression. PLoS One. 2012;7(11):e49288.
   PubMed Web of Science ®Google Scholar
• Li J, Li J, Liu X, et al. MicroRNA expression profile and functional analysis reveal that miR-382 is a critical novel gene of alcohol addiction. EMBO Mol Med. 2013;5(9):1402–1414.
   PubMed Web of Science ®Google Scholar
• Froger A, Hall JE. Transformation of plasmid DNA into E. coli using the heat shock method. J. Vis. Exp. 2007;6(6):253.
   Google Scholar
• Walker JM. The bicinchoninic acid (BCA) assay for protein quantitation. Methods Mol Biol. 1994;32:5–8.
   PubMedGoogle Scholar
• Girish V, Vijayalakshmi A. Affordable image analysis using NIH Image/ImageJ. Indian J Cancer. 2004;41(1):47.
   PubMedGoogle Scholar
• Agarwal V, Bell GW, Nam JW, et al. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.
   PubMed Web of Science ®Google Scholar
• Betel D, Wilson M, Gabow A, et al. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2007;36(Database):D149–D153.
   PubMed Web of Science ®Google Scholar
• Blasiak E, Lukasiewicz S, Szafran-Pilch K, et al. Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor. Pharmacol Rep. 2017;69(2):235–241.
   PubMed Web of Science ®Google Scholar
• Levay G, Bodell WJ. Detection of dopamine–DNA adducts: potential role in Parkinson’s disease. Carcinogenesis. 1993;14(6):1241–1245.
   PubMed Web of Science ®Google Scholar
• Caldinelli L, Sacchi S, Molla G, et al. Characterization of human DAAO variants potentially related to an increased risk of schizophrenia. Biochimica et Biophysica Acta. 2013;1832(3):400–410.
   PubMed Web of Science ®Google Scholar
• Cappelletti P, Tallarita E, Rabattoni V, et al. Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line. PLoS One. 2018;13(4):e0196283.
   PubMed Web of Science ®Google Scholar
• Wang J, Bannon MJ. Sp1 and Sp3 activate transcription of the human dopamine transporter gene. J Neurochem. 2005;93(2):474–482.
   PubMed Web of Science ®Google Scholar
• Gangolli EA, Conneely OM, O’Malley BW. Neurotransmitters activate the human estrogen receptor in a neuroblastoma cell line. J Steroid Biochem Mol Biol. 1997;61(1–2):1–9.
   PubMed Web of Science ®Google Scholar
• Ajjimaporn A, Shavali S, Ebadi M, et al. Zinc rescues dopaminergic SK-N-SH cell lines from methamphetamine-induced toxicity. Brain Res Bull. 2008;77(6):361–366.
   PubMed Web of Science ®Google Scholar
• Moszczynska A, Saleh J, Zhang H, et al. Parkin disrupts the alpha-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity. J Mol Neurosci. 2007;32(3):217–227.
   PubMed Web of Science ®Google Scholar
• Asai T, Bundo M, Sugawara H, et al. Effect of mood stabilizers on DNA methylation in human neuroblastoma cells. Int J Neuropsychopharmacol. 2013;16(10):2285–2294.
   PubMed Web of Science ®Google Scholar
• Xie HR, Hu LS, Li GY. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson’s disease. Chin Med J. 2010;123(8):1086–1092.
   PubMed Web of Science ®Google Scholar
• Shin JH, Park SJ, Kim ES, Jo YK, et al. Sertindole, a potent antagonist at dopamine D- receptors, induces autophagy by increasing reactive oxygen species in SH-SY5Y neuroblastoma cells. Biol Pharm Bull. 2012;35(7):1069–1075.
   PubMed Web of Science ®Google Scholar
• Deslauriers J, Lefrancois M, Larouche A, et al. Antipsychotic-induced DRD2 upregulation and its prevention by alpha-lipoic acid in SH-SY5Y neuroblastoma cells. Synapse. 2011;65(4):321–331.
   PubMed Web of Science ®Google Scholar
• Millar JK, Pickard BS, Mackie S, et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science. 2005;310(5751):1187–1191.
   PubMed Web of Science ®Google Scholar
• Liu LF, Wang Y. Cellular function of microRNA-15 family. Sheng li Xue Bao. 2012;64(1):101–106.
   PubMedGoogle Scholar
• Tijsen AJ, van der Made I, van den Hoogenhof MM, et al. The microRNA-15 family inhibits the TGFbeta-pathway in the heart. Cardiovasc Res. 2014;104(1):61–71.
   PubMed Web of Science ®Google Scholar
• Navarro A, Diaz T, Gallardo E, et al. Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer. J Surg Oncol. 2011;103(5):411–415.
   PubMed Web of Science ®Google Scholar
• Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA. 2005;102(39):13944–13949.
   PubMed Web of Science ®Google Scholar
• Pothof J, Verkaik NS, van IW, et al. MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J. 2009;28(14):2090–2099.
   PubMed Web of Science ®Google Scholar
• Sullivan RP, Leong JW, Schneider SE, et al. MicroRNA-15/16 antagonizes Myb to control NK cell maturation. J Immunol. 2015;195(6):2806–2817.
   PubMed Web of Science ®Google Scholar
• Janaki Ramaiah M, Lavanya A, Honarpisheh M, et al. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells. Gene. 2014;552(2):255–264.
   PubMed Web of Science ®Google Scholar
• Hansen TB, Wiklund ED, Bramsen JB, et al. Kjems J: miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO J. 2011;30(21):4414–4422.
   PubMed Web of Science ®Google Scholar
• Rossi JJ. A novel nuclear miRNA mediated modulation of a non-coding antisense RNA and its cognate sense coding mRNA. EMBO J. 2011;30(21):4340–4341.
   PubMed Web of Science ®Google Scholar
• Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science. 2004;304(5670):594–596.
   PubMed Web of Science ®Google Scholar
• Shi S, Leites C, He D, et al. MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant. J Biol Chem. 2014;289(19):13434–13444.
   PubMed Web of Science ®Google Scholar